11 completed, 6 terminated, 4 suspended, 1 unknown. 17 Phase 1, 8 Phase 2, 1 Phase 4.
By phase and status
Follow Piramal Enterprises Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
P1446A-05 - Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) | Phase 1 | Suspended | Piramal Enterprises Limited | 36 | 2014-06-01 | 2014-09-03 |
Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation
P1446A-05, Vemurafenib (Zelboraf®) - Advanced or Inoperable Malignant Melanoma With BRAF Mutation | Phase 1 | Suspended | Piramal Enterprises Limited | 100 | 2013-08-01 | 2014-09-04 |
Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects
P7435, Placebo - Healthy | Phase 1 | Completed | Piramal Enterprises Limited | 100 | 2013-08-01 | 2014-11-26 |
Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187
P11187, Placebo - Overweight, Diabetes Mellitus Type 2 in Obese | Phase 1 | Unknown | Piramal Enterprises Limited | 96 | 2013-06-01 | 2014-08-28 |
Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors
PL225B - Advanced Refractory Solid Tumors | Phase 1 | Suspended | Piramal Enterprises Limited | 70 | 2012-12-01 | 2014-09-29 |
Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors
P7170 - Advanced Refractory Solid Tumors | Phase 1 | Suspended | Piramal Enterprises Limited | 60 | 2012-09-01 | 2014-09-29 |
A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00
P276-00, Radiation Therapy, Cisplatin - Radiation Induced Mucositis in Head and Neck Cancer | Phase 2 | Completed | Piramal Enterprises Limited | 73 | 2012-07-01 | 2014-09-04 |
Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects
P7435 - Healthy, Overweight and/or Obese Subjects | Phase 1 | Terminated | Piramal Enterprises Limited | 32 | 2012-05-01 | 2013-07-09 |
A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin
Gemcitabine and Carboplatin, P276-00 along with Gemcitabine and carboplatin - Breast Cancer | Phase 1 | Terminated | Piramal Enterprises Limited | 11 | 2011-08-01 | 2014-09-04 |
Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects and Efficacy & Safety of P3914 in Patients With Acute Dental Pain
P3914, Placebo - Acute Dental Pain | Phase 1 | Terminated | Piramal Enterprises Limited | 46 | 2011-06-01 | 2012-11-22 |
A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes
P2202, Placebo - Type 2 Diabetes Mellitus | Phase 2 | Terminated | Piramal Enterprises Limited | 48 | 2011-04-01 | 2013-08-05 |
A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis
TINEFCON - Plaque Psoriasis | Phase 4 | Completed | Piramal Enterprises Limited | 298 | 2010-12-01 | 2012-11-22 |
A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
P276-00 - Mantle Cell Lymphoma | Phase 2 | Terminated | Piramal Enterprises Limited | 13 | 2009-11-01 | 2012-07-27 |
Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer
P276-00, External beam radiotherapy (EBRT) - Squamous Cell Carcinoma of Head and Neck | Phase 1 / Phase 2 | Completed | Piramal Enterprises Limited | 23 | 2009-08-01 | 2012-11-22 |
Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer
P276-00, Gemcitabine - Pancreatic Cancer | Phase 1 / Phase 2 | Completed | Piramal Enterprises Limited | 23 | 2009-05-01 | 2012-01-20 |
Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
P276-00 - Melanoma | Phase 2 | Completed | Piramal Enterprises Limited | 12 | 2009-05-01 | 2012-12-04 |
A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies
P1446A-05 - Cancer | Phase 1 | Completed | Piramal Enterprises Limited | 39 | 2008-12-01 | 2012-11-22 |
Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma
P276-00 - Multiple Myeloma | Phase 1 | Withdrawn | Piramal Enterprises Limited | 35 | 2008-12-01 | 2009-04-23 |
A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies
P1446A-05 - Solid Tumor, Hematologic Malignancy | Phase 1 | Completed | Piramal Enterprises Limited | 29 | 2008-12-01 | 2012-11-21 |
A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer
P276-00 - Squamous Cell Carcinoma of Head and Neck | Phase 2 | Completed | Piramal Enterprises Limited | 86 | 2008-09-01 | 2013-07-10 |
Showing 20 of 23. Sign in to see all of them.
Conditions studied
Neoplasms (3) · Melanoma (2) · Multiple Myeloma (2) · Overweight (2) · Squamous Cell Carcinoma of Head and Neck (2) · Breast Neoplasms (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Head and Neck Neoplasms (1) · Hematologic Neoplasms (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Mantle-Cell (1) · Pancreatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Interventions
P276-00 (10) · Gemcitabine (2) · Radiotherapy (2) · Carboplatin (1) · Cisplatin (1) · P7170 compound (1) · Vemurafenib (1)
Countries
India (14) · United States (8) · Canada (3) · Australia (1) · New Zealand (1)
Top investigators
Raghunadharao D, MD, DM (2) · Raj Nagarkar, MS (2) · Adil Daud, MD (1) · Ajay Gopal, MD (1) · Ajay Mehta, MS (1) · Amol Bapaye, MS (1) · Anand Pathak, MD (1) · Andre Goy, MD (1) · Anish Maru, D.M. (1) · Anita Ramesh, MD (1) · Anthony El-Khoueiry, MD (1) · Balaji Shewalkar, MD, DNB (1) · Brad Kahl, MD (1) · Cecil Ross, MD (1) · Christian K Kollmannsberger, MD (1)
Results publications
PMID 19238148